Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-03

Clinical Trial Update: A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated different doses of LC350189 for efficacy and safety in patients with gout and hyperuricemia; trial results have been completed and pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LC350189

Snippet

Sponsor: LG Chem | Conditions: Gout, Hyperuricemia | Phase 2 | Status: COMPLETED | Results posted: 2025-12-03